Prostate brachytherapy after ileal pouch-anal anastomosis reconstruction

Urology
Richard WilliamsonRonald M Benoit

Abstract

To determine the safety of prostate brachytherapy in patients with clinically localized prostate cancer who have undergone proctocolectomy with ileal pouch-anal anastomosis (IPAA). We performed a retrospective chart review of patients with a prior history of IPAA reconstruction who underwent prostate brachytherapy at our institution. Clinical records were reviewed for demographic characteristics, postoperative dosimetry, changes in bowel function, and oncologic outcomes. Data were analyzed using descriptive statistics. Five patients with an IPAA underwent prostate brachytherapy for clinically localized prostate cancer. Mean time from colorectal reconstruction to prostate brachytherapy was 6.3 years. Adequate dosimetry (mean D90 114.9%, mean V100 91.1%, mean R100 0.76 mL) was achieved in each patient. Bowel frequency worsened in the immediate postoperative period in all patients, but all patients returned to their baseline bowel pattern by 4 months after their procedure. Serious complications, such as J-pouch ulcers, fistulas, or fecal incontinence, did not occur in these patients. Prostate brachytherapy is a safe treatment option in patients with clinically localized prostate cancer and a history of proctocolectomy and IPAA rec...Continue Reading

References

Jul 8, 1978·British Medical Journal·A G Parks, R J Nicholls
May 15, 1991·International Journal of Radiation Oncology, Biology, Physics·B EmamiM Wesson
Oct 1, 1987·Annals of Surgery·J H PembertonD M Ilstrup
Jan 9, 1998·International Journal of Radiation Oncology, Biology, Physics·A Grann, K Wallner
Mar 8, 2000·International Journal of Radiation Oncology, Biology, Physics·C G WillettD K Podolsky
Aug 5, 2000·International Journal of Radiation Oncology, Biology, Physics·D Y Gelblum, L Potters
Sep 25, 2001·International Journal of Radiation Oncology, Biology, Physics·D Y SongT L DeWeese
Mar 7, 2006·Diseases of the Colon and Rectum·Feza H RemziIan C Lavery
Aug 5, 2006·International Journal of Radiation Oncology, Biology, Physics·Christopher A PetersRichard G Stock
Sep 15, 2006·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·J J Y Tan, J J Tjandra
Jun 16, 2007·The British Journal of Surgery·B B McGuireP R O'Connell

❮ Previous
Next ❯

Citations

Feb 2, 2010·Journal of the American College of Surgeons·Eric C UmbreitMichael L Blute
Dec 2, 2014·Inflammatory Bowel Diseases·Haluk T Kani, Bo Shen
Feb 17, 2015·Korean journal of urology·Mahmoud MustafaLouis Pisters
Nov 10, 2018·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·A L LightnerP Fleshner
May 6, 2021·Diseases of the Colon and Rectum·Amy L LightnerTracy L Hull

❮ Previous
Next ❯

Related Concepts

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.